Infections in Hospitalized Patients with Psoriasis in a Skin Referral Hospital

被引:2
作者
Zaredar, Nafise [1 ]
Mahmoudi, Hamidreza [1 ,2 ]
Soori, Tahereh [1 ,3 ]
Teimourpour, Amir [1 ]
Balighi, Kamran [1 ,2 ]
Farid, Ali Salehi [1 ,2 ]
Daneshpazhooh, Maryam [1 ,2 ,4 ]
机构
[1] Univ Tehran Med Sci, Dept Dermatol, Tehran, Iran
[2] Univ Tehran Med Sci, Autoimmune Bullous Dis Res Ctr, Tehran, Iran
[3] Univ Tehran Med Sci, Dept Infect Dis, Tehran, Iran
[4] Razi Hosp, Vahdate Eslami Sq, Tehran 11996, Iran
关键词
psoriasis; infection; biologic treatment; anti-TNFa; methotrexate; SERIOUS INFECTIONS; BIOLOGIC THERAPIES; RISK;
D O I
10.5826/dpc.1301a27
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction: Psoriasis and its treatments may predispose patients to various infections. This is considered one of the most significant complications in patients with psoriasis. Objectives: In the present study, we aimed to determine the prevalence of infection in hospitalized psoriasis patients and its relationship with systemic and biologic treatments. Methods: All hospitalized patients with psoriasis from 2018 to 2020 in Razi Hospital in Tehran, Iran, were studied and cases of infection were recorded. Results: Overall, 516 patients were studied and 25 types of infection in 111 patients were found. The most common types of infection were pharyngitis and cellulitis, followed by oral candida, urinary tract infections, common cold, fever of unknown origin, and pneumonia. Female sex and pustular psoriasis were significantly associated with infection in psoriatic patients. Those patients who received prednisolone had a higher risk of infection, and those under treatment with methotrexate or infliximab had a lower risk of infection. Conclusion: Overall, 21.5% of psoriasis patients in our study had at least one episode of infection. This demonstrates that the prevalence of infection in these patients is not low. Using systemic steroids was associated with a higher risk of infection, while using methotrexate or infliximab was concomitant with a lower risk of infection.
引用
收藏
页数:7
相关论文
共 17 条
[1]   Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial [J].
Al Salman, Mohammad ;
Ghiasi, Maryam ;
Farid, Ali Salehi ;
Taraz, Mohammad ;
Azizpour, Arghavan ;
Mahmoudi, Hamidreza .
DERMATOLOGIC THERAPY, 2021, 34 (05)
[2]   Rate of serious infection in patients who are prescribed systemic biologic or nonbiologic agents for psoriasis: A large, single center, retrospective, observational cohort study [J].
Carneiro, Chantelle ;
Bloom, Romi ;
Ibler, Erin ;
Majewski, Sara ;
Sable, Kimberly A. ;
Guido, Nicholas J. ;
Day, Jennifer ;
Nocadello, Salvatore ;
Florek, Aleksandra G. ;
West, Dennis P. ;
Nardone, Beatrice .
DERMATOLOGIC THERAPY, 2017, 30 (05)
[3]   Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry [J].
Davila-Seijo, Paula ;
Dauden, Esteban ;
Descalzo, M. A. ;
Carretero, Gregorio ;
Carrascosa, Jose-Manuel ;
Vanaclocha, Francisco ;
Gomez-Garcia, Francisco-Jose ;
de la Cueva-Dobao, Pablo ;
Herrera-Ceballos, Enrique ;
Belinchon, Isabel ;
Lopez-Estebaranz, Jose-Luis ;
Alsina, Merce ;
Sanchez-Carazo, Jose-Luis ;
Ferran, Marta ;
Torrado, Rosa ;
Ferrandiz, Carlos ;
Rivera, Raquel ;
Llamas, Mar ;
Jimenez-Puya, Rafael ;
Garcia-Doval, Ignacio .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (02) :313-321
[4]   The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis [J].
Dincer Rota, Didem ;
Tanacan, Efsun .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
[5]   Risk of serious infections, cutaneous bacterial infections, and granulomatous infections in patients with psoriasis treated with anti-tumor necrosis factor agents versus classic therapies: Prospective meta-analysis of Psonet registries [J].
Garcia-Doval, Ignacio ;
Cohen, Arnon D. ;
Cazzaniga, Simone ;
Feldhamer, Ilan ;
Addis, Antonio ;
Carretero, Gregorio ;
Ferrandiz, Carlos ;
Stern, Robert S. ;
Naldi, Luigi .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (02) :299-+
[6]   Serious infections in hospitalized patients with psoriasis in the United States [J].
Hsu, Derek Y. ;
Gordon, Kenneth ;
Silverberg, Jonathan I. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (02) :287-296
[7]   Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR) [J].
Kalb, Robert E. ;
Fiorentino, David F. ;
Lebwohl, Mark G. ;
Toole, John ;
Poulin, Yves ;
Cohen, Arnon D. ;
Goyal, Kavitha ;
Fakharzadeh, Steven ;
Calabro, Stephen ;
Chevrier, Marc ;
Langholff, Wayne ;
You, Yin ;
Leonardi, Craig L. .
JAMA DERMATOLOGY, 2015, 151 (09) :961-969
[8]   Oral Candida colonization and plaque type psoriasis: Is there any relationship? [J].
Lesan, Simin ;
Toosi, Roja ;
Aliakbarzadeh, Reza ;
Daneshpazhooh, Maryam ;
Mahmoudi, Leila ;
Tavakolpour, Soheil ;
Mahmoudi, Hamidreza .
JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY, 2018, 9 (03) :e12335
[9]   National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study [J].
Parisi, Rosa ;
Iskandar, Ireny Y. K. ;
Kontopantelis, Evangelos ;
Augustin, Matthias ;
Griffiths, Christopher E. M. ;
Ashcroft, Darren M. .
BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
[10]   Prevalence and Possible Role of Candida Species in Patients with Psoriasis: A Systematic Review and Meta-Analysis [J].
Pietrzak, Aldona ;
Grywalska, Ewelina ;
Socha, Mateusz ;
Rolinski, Jacek ;
Franciszkiewicz-Pietrzak, Kinga ;
Rudnicka, Lidia ;
Rudzki, Marcin ;
Krasowska, Dorota .
MEDIATORS OF INFLAMMATION, 2018, 2018